Trial intelligence / Profile preview

Antibiotics versus laparoscopic appendicectomy for uncomplicated appendicitis

ACTRN12618001229268Phase 3Recruiting

Sponsor
Townsville University Hospital
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ceftriaxone, metronidazole and amoxicillin + clavulanic acid in appendicitis (2 arms), sponsored by Townsville University Hospital. Primary endpoints: Freedom from appendicectomy within 6 weeks and Successful appendicectomy. Started Dec 2018; status: recruiting.

02

Drugs

ceftriaxonemetronidazoleamoxicillin + clavulanic acid
03

Conditions

appendicitis

Beyond the preview

Go deeper on ACTRN12618001229268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001229268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call